Medscape www.medscape.com

References for:
Critical Appraisal of the Literature

[J Am Board Fam Pract 12(4):315-333, 1999. © 1999 American Board of Family Practice]

  1. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995;332:1589-93.
  2. Stampfer MJ, Willett WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl J Med 1985;313:1044-9.
  3. Wilson P, Garrison R, Castelli W. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med 1985;313:1038-43.
  4. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991;325:756-62.
  5. Guidelines for counseling postmenopausal women about preventive hormone therapy. American College of Physicians. Ann Intern Med 1992;117:1038-41.
  6. Gorsky RD, Koplan JP, Peterson HB, Thacker SB. Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis. Obstet Gynecol 1994;83:161-6.
  7. Dupont WD, Page DL. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991;15:67-72.
  8. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1995;273:199-208.
  9. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995;274:137-42.
  10. Slawson DC, Shaughnessy AF, Bennett JH. Becoming a medical information master: feeling good about not knowing everything. J Fam Pract 1994;38:505-13.
  11. Shaughnessy AF, Slawson DC, Bennett JH. Becoming an information master: a guidebook to the medical information jungle. J Fam Pract 1994;39:489-99.
  12. Fletcher R, Fletcher S. Keeping clinically up-to-date. Evidence-based approach to the medical literature. J Gen Intern Med 1997;12(Suppl):S5-S14.
  13. Lock S. Does editorial peer review work? Ann Intern Med 1994;121:60-1.
  14. Sonis J, Joines J. The quality of clinical trials published in The Journal of Family Practice, 1974-1991. J Fam Pract 1994;39:225-35.
  15. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-9.
  16. Altman DG. The scandal of poor medical research: we need less research, better research, and research done for the right reasons. BMJ 1994;308:283-4.
  17. Reid MC, Lachs MS, Feinstein AR. Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA 1995;274:645-51.
  18. Guyatt GH, Rennie D. Users' guides to the medical literature. JAMA 1993;270:2096-7.
  19. How to read clinical journals: I. Why to read them and how to start reading them critically. Can Med Assoc J 1981;124;555-8.
  20. How to read clinical journals: II. To learn about a diagnostic test. Can Med Assoc J 1981;124:703-10.
  21. How to read clinical journals: III. To learn the clinical course and prognosis of disease. Can Med Assoc J 1981;124:869-72.
  22. How to read clinical journals: IV. To determine etiology or causation. Can Med Assoc J 1981;124:985-90.
  23. How to read clinical journals: V. To distinguish useful from useless or even harmful therapy. Can Med Assoc J 1981;124:1156-62.
  24. Oxman AD, Sackett DL, Guyatt GH. Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA 1993;270:2093-5.
  25. Guyatt GH Sackett DL, Cook DJ. Users' guides to the medical literature. II. How to use an article about therapy or prevention? A. Are the results of the study valid? The Evidence-Based Medicine Working Group. JAMA 1993;270:2598-601.
  26. Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature. II. How to use an article about therapy or prevention? B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1994;271:59-63.
  27. Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1994;271:389-91.
  28. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1994;271:703-7.
  29. Levine M, Walter S, Lee H, Haines T, Holbrook A, Moyer V. Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA 1994;271:1615-9.
  30. Laupacis A, Wells G, Richardson WS, Tugwell P. Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group. JAMA 1994;272:234-7.
  31. Oxman AD, Cook DJ, Guyatt GH. Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA 1994;272:1367-71.
  32. Richardson WS, Detsky AS. Users' guides to the medical literature. VII. How to use a clinical decision analysis. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1995;273:1292-5.
  33. Richardson WS, Detsky AS. Users' guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1995;273:1610-3.
  34. Hayward RS, Wilson MC, Tunis SR, Bass EB, Guyatt GH. Users' guides to the medical literature. VIII. How to use clinical practice guidelines. A. Are the recommendations valid? Evidence-Based Medicine Working Group. JAMA 1995;274:570-4.
  35. Wilson MC, Hayward RS, Tunis SR, Bass EB, Guyatt GH. Users' guides to the medical literature. VIII. How to use clinical practice guidelines. B. What are the recommendations and will they help you in caring for your patients? Evidence-Based Medicine Working Group. JAMA 1995;274:1630-2.
  36. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 1995;274:1800-4.
  37. Naylor CD, Guyatt GH. Users' guides to the medical literature. X. How to use an article reporting variations in the outcomes of health services. Evidence-Based Medicine Working Group. JAMA 1996;275:554-8.
  38. Naylor CD, Guyatt GH. Users' guides to the medical literature. XI. How to use an article about a clinical utilization review. Evidence-Based Medicine Working Group. JAMA 1996;275:1435-9.
  39. Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ. Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. JAMA 1997;277:1232-7.
  40. Drummond MF, Richardson WS, O'Brien BJ, Levine M, Heyland D. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1997;277:1552-7.
  41. O'Brien BJ, Heyland D, Richardson WS, Levine M, Drummond MF. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1997;277:1802-6.
  42. Dans AL, Dans LF, Guyatt GH, Richardson S. Users' guides to the medical literature. XIV. How to decide on the applicability of clinical trial results to your patients. Evidence-Based Medicine Working Group. JAMA 1998;279:545-9.
  43. Richardson WS, Wilson MC, Guyatt GH, Cook DJ, Nishikawa J. Users' guide to the medical literature. XV. How to use an article about disease probability for differential diagnosis. The Evidence-Based Medicine Working Group. JAMA 1999;281:1214-19.
  44. Klassen TP, Craig WP, Moher D, Osmond MH, Pasterkamp H, Sutcliffe T, et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA 1998; 279:1629-32.
  45. Slawson DC, Shaughnessy AF, Ebell MW, Barry HC. Mastering medical information and the role of POEMs - Patient-Oriented Evidence that Matters. J Fam Pract 1997;45:195-6.
  46. Kassirer JP, Campion EW. Peer review. Crude and understudied, but indispensable. JAMA 1994;272:96-7.
  47. Abby M, Massey MD, Galandiuk S, Polk HC Jr. Peer review is an effective screening process to evaluate medical manuscripts. JAMA 1994;272:105-7.
  48. Goodman SN, Berlin J, Fletcher SW, Fletcher RH. Manuscript quality before and after peer review and editing at Annals of Internal Medicine. Ann Intern Med 1994;121:11-21.
  49. Gardner MJ, Bond J. An exploratory study of statistical assessment of papers published in the British Medical Journal. JAMA 1990;263:1355-7.
  50. Justice AC, Berlin JA, Fletcher SW, Fletcher RH, Goodman SN. Do readers and peer reviewers agree on manuscript quality? JAMA 1994;272:117-9.
  51. Colaianni LA. Peer review in journals indexed in Index Medicus. JAMA 1994;272:156-8.
  52. Dickersin K, Min YI, Meinert CL. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA 1992;267: 374-8.
  53. Jadad AR, Rennie D. The randomized controlled trial gets a middle-aged checkup. JAMA 1998;279:319-20.
  54. Rennie D, Flanagin A. Publication bias. The triumph of hope over experience. JAMA 1992;267:411-2.
  55. Scherer RW, Dickersin K, Langenberg P. Full publication of results initially presented in abstracts. A meta-analysis. JAMA 1994;272:158-62.
  56. Ioannidis JP. Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 1998;279:281-6.
  57. Whitely WP, Rennie D, Hafner AW. The scientific community's response to evidence of fraudulent publication. The Robert Slutsky case. JAMA 1994;272:170-3.
  58. Bero LA, Galbraith A, Rennie D. The publication of sponsored symposiums in medical journals. N Engl J Med 1992;327:1135-40.
  59. Rochon PA, Gurwitz JH, Cheung CM, Hayes JA, Chalmers TC. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA 1994;272:108-13.
  60. Greenhalgh T. How to read a paper - Getting your bearings (deciding what the paper is about). BMJ 1997;315:243-6.
  61. Franks P. Clinical trials. Fam Med 1988;20:443-8.
  62. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994;272:125-8.
  63. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
  64. O'Brien PC, Shampo MA. Statistics for clinicians. 1. Descriptive statistics. Mayo Clin Proc 1981;56:47-9.
  65. Greenhalgh T. How to read a paper. Statistics for the non-statistician. I: different types of data need different statistical tests. BMJ 1997;315:364-6.
  66. Grimes DA. The case for confidence intervals. Obstet Gynecol 1992;80:865-6.
  67. Simon R. Confidence intervals for reporting results of clinical trials. Ann Intern Med 1986;105:429-35.
  68. Braitman LE. Confidence intervals assess both clinical significance and statistical significance. Ann Intern Med 1991;114:515-7.
  69. Gehlbach SH. Interpreting the medical literature. 3rd ed. New York: McGraw-Hill, 1992.
  70. Detsky AS, Sackett DL. When was a "negative" clinical trial big enough? How many patients you needed depends on what you found. Arch Intern Med 1985;145:709-12.
  71. Raju TN, Langenberg P, Sen A, Aldana O. How much "better" is good enough? The magnitude of treatment effect in clinical trials. Am J Dis Child 1992;146:407-11.
  72. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994;272:122-4.
  73. Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978;299:690-4.
  74. Mengel MB, Davis AB. The statistical power of family practice research. Fam Pract Res J 1993;13:105-11.